慢性气道疾病（支扩、慢阻肺、哮喘、ABPA等）的临床和转化医学研究

Clinical and Translational Research on chronic airway disease (Bronchiectasis, COPD, Asthma, ABPA et al)

上海市肺科医院呼吸与危重症医学科气道疾病亚专科负责人；

上海市医师协会内科医师分会 委员；

上海市医学会呼吸病学分会 青委副主委；

国家自然科学基金 评审专家；

国家科技专家库 科技专家

Head of the Airway Diseases Subspecialty, Department of Respiratory and Critical Care Medicine, Shanghai Pulmonary Hospital;

Member of the internal medicine Branch of the Shanghai Medical Association;

Vice President of the Youth Committee of the Respiratory Disease Branch of the Shanghai Medical Association;

Expert Reviewer, National Natural Science Foundation of China (NSFC);

Technology experts of National Science and Technology expert database of science

上海市肺科医院“三峰人才计划”（2025）、上海市“东方英才计划拔尖项目”（2024）和上海市“浦江人才”（2021）入选者，主持国家科技重大专项青年科学家项目（2024）、国家自然科学基金面上项目（2022、2025）及国家自然科学基金青年项目（2015）等多项国家级科研项目；以第一作者或通讯作者（含共同）发表SCI论文40余篇，发表于 Am J Respir Crit Care Med、Eur Respir J、CHEST、AnnalsATS 等国际权威期刊，研究成果多次被 NEJM、Lancet、JAMA、Lancet Respir Med 等顶级期刊正面评价和引用，其中12篇论文被国际支气管扩张症指南等权威文献引用23次；担任 Eur Respir Rev（Q1区，影响因子10.3）青年编委，并执笔撰写《成人支气管扩张症病因学诊断专家共识》（2024）。

Recipient of the Shanghai Pulmonary Hospital “Three Peaks Talent Program” (2025), the Shanghai “Oriental Talent Program - Top Talent Project” (2024), and the Shanghai “Pujiang Talent Program” (2021). He is the principal investigator of multiple national research grants, including the National Science and Technology Major Project for Young Scientists (2024), National Natural Science Foundation of China (NSFC) General Program grants (2022, 2025), and NSFC Youth Program grants (2015). He has published more than 40 SCI papers as first or corresponding author, in prestigious international journals such as American Journal of Respiratory and Critical Care Medicine, European Respiratory Journal, CHEST, and Annals of the American Thoracic Society. His research findings have been positively highlighted and cited by top-tier journals including NEJM, Lancet, JAMA, and Lancet Respiratory Medicine. Twelve of his papers have been cited 23 times in international bronchiectasis guidelines and other authoritative documents. He serves as a Youth Editorial Board Member of European Respiratory Review (Q1, Impact Factor 10.3) and was a key writer of the Expert Consensus on Etiological Diagnosis of Adult Bronchiectasis (2024).